BioMarin's Novel Treatment Promises to Disrupt Competitors

BioMarin's Novel Treatment Promises to Disrupt Competitors

Source: 
Motley Fool
snippet: 

The gene therapy maker's novel medicine has the potential to take over a highly competitive market and offer growth opportunities for investors.